ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Trends in Molecular Medicine
Volume 13, Issue 5, May 2007, Pages 175-182
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (409 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.molmed.2007.03.004    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier Ltd All rights reserved.

Opinion

The prognosis of latent tuberculosis: can disease be predicted?

Peter Andersen1, E-mail The Corresponding Author, T. Mark Doherty1, Madhukar Pai2 and Karin Weldingh1

1Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, DK-2300 Copenhagen S, Denmark 2McGill University, Department of Epidemiology, Biostatistics & Occupational Health, Montreal H3A 1A2, Quebec, Canada

Available online 5 April 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

In humans, Mycobacterium tuberculosis persists for long periods in a clinically latent state, creating a huge reservoir of 'silent’ tuberculosis (TB) (roughly one-third of the global population) from which new cases continually arise. A prognostic marker for active TB would enable targeted treatment of the small fraction of infected individuals who are most at risk of developing contagious TB, contributing greatly to TB control efforts. Here, we propose that TB-specific interferon-γ release assays might be useful for identifying individuals with progressive infections who are likely to develop the disease. This might provide an unprecedented advantage for TB control, namely targeted preventive therapy for individuals who are most at risk of developing active contagious TB.

Article Outline

The global challenge of latent tuberculosis
TB infection, immune responses and diagnosis
The tuberculin skin test
Discovery and characteristics of M. tuberculosis-specific antigens
The novel specific tests – upgrading diagnosis of TB from induration to IFN-γ
Correlation between T-cell responses to ESAT-6 and CFP-10, and disease progression in animal models
Correlation between T-cell responses to ESAT-6 and CFP-10, and clinical outcome
The potential use of IFN-γ assay as a prognostic test
Concluding remarks
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.